+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Cancer Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Gene Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Kaposi Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Kaposi Sarcoma - Global Strategic Business Report

  • Report
  • October 2025
  • 309 Pages
  • Global
From
From
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Cancer Cachexia - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Cachexia - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
STAT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 450 Pages
  • Global
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
T-Cell Malignancies - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Malignancies - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
From
Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2025 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hepatic - Colorectal Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic - Colorectal Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Adenomatous Polyposis Coli - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anti-Lymphotoxin - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-Lymphotoxin - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more